No.  GlobalCures’ research will either validate or disprove some of the more promising therapies that fall under this rubric.  A negative result will also have considerable value, saving time and money, especially to patients with cancer, who can ill afford to try therapies not known to be efficacious.  It should be noted that some of GlobalCures’ candidates are as “targeted” as the newest cancer therapies, but they have not been tested rigorously in humans.